Literature DB >> 35595182

KRAS alterations in colorectal liver metastases: shifting to exon, codon, and point mutations.

Pim B Olthof1, Stefan Buettner1, Nikolaos Andreatos2, Jane Wang3, Inger Marie Løes4, Doris Wagner5, Kazunari Sasaki6, Andrea Macher-Beer7, Carsten Kamphues8, Ioannis Pozios8, Hendrik Seeliger8, Daisuke Morioka9, Katsunori Imai9, Klaus Kaczirek10, Timothy M Pawlik11, George Poultsides12, Richard Burkhart3, Itaru Endo9, Hideo Baba13, Peter Kornprat5, Federico N Aucejo6, Per Eystein Lønning4, Katharina Beyer8, Matthew J Weiss14, Christopher L Wolfgang15, Martin E Kreis8, Georgios A Margonis8,16.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35595182      PMCID: PMC9380990          DOI: 10.1093/bjs/znac147

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   11.122


× No keyword cloud information.
  13 in total

1.  Kirsten ras mutations in patients with colorectal cancer: the multicenter "RASCAL" study.

Authors:  H J Andreyev; A R Norman; D Cunningham; J R Oates; P A Clarke
Journal:  J Natl Cancer Inst       Date:  1998-05-06       Impact factor: 13.506

2.  Association Between Specific Mutations in KRAS Codon 12 and Colorectal Liver Metastasis.

Authors:  Georgios Antonios Margonis; Yuhree Kim; Gaya Spolverato; Aslam Ejaz; Rohan Gupta; David Cosgrove; Robert Anders; Georgios Karagkounis; Michael A Choti; Timothy M Pawlik
Journal:  JAMA Surg       Date:  2015-08       Impact factor: 14.766

3.  RAS mutation status predicts survival and patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases.

Authors:  Jean-Nicolas Vauthey; Giuseppe Zimmitti; Scott E Kopetz; Junichi Shindoh; Su S Chen; Andreas Andreou; Steven A Curley; Thomas A Aloia; Dipen M Maru
Journal:  Ann Surg       Date:  2013-10       Impact factor: 12.969

Review 4.  Meta-analysis of KRAS mutations and survival after resection of colorectal liver metastases.

Authors:  K W Brudvik; S E Kopetz; L Li; C Conrad; T A Aloia; J-N Vauthey
Journal:  Br J Surg       Date:  2015-07-21       Impact factor: 6.939

5.  Specific mutations in KRAS codons 12 and 13, and patient prognosis in 1075 BRAF wild-type colorectal cancers.

Authors:  Yu Imamura; Teppei Morikawa; Xiaoyun Liao; Paul Lochhead; Aya Kuchiba; Mai Yamauchi; Zhi Rong Qian; Reiko Nishihara; Jeffrey A Meyerhardt; Kevin M Haigis; Charles S Fuchs; Shuji Ogino
Journal:  Clin Cancer Res       Date:  2012-07-02       Impact factor: 12.531

6.  BRAF codons 594 and 596 mutations identify a new molecular subtype of metastatic colorectal cancer at favorable prognosis.

Authors:  C Cremolini; M Di Bartolomeo; A Amatu; C Antoniotti; R Moretto; R Berenato; F Perrone; E Tamborini; G Aprile; S Lonardi; A Sartore-Bianchi; G Fontanini; M Milione; C Lauricella; S Siena; A Falcone; F de Braud; F Loupakis; F Pietrantonio
Journal:  Ann Oncol       Date:  2015-07-07       Impact factor: 32.976

7.  Factors influencing the natural history of colorectal liver metastases.

Authors:  R Stangl; A Altendorf-Hofmann; R M Charnley; J Scheele
Journal:  Lancet       Date:  1994-06-04       Impact factor: 79.321

8.  Association of RAS Mutation Location and Oncologic Outcomes After Resection of Colorectal Liver Metastases.

Authors:  Lily V Saadat; Thomas Boerner; Debra A Goldman; Mithat Gonen; Timothy L Frankel; Efsevia Vakiani; T Peter Kingham; William R Jarnagin; Alice C Wei; Kevin C Soares; David B Solit; Michael I D'Angelica
Journal:  Ann Surg Oncol       Date:  2020-07-18       Impact factor: 5.344

9.  Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study.

Authors:  H J Andreyev; A R Norman; D Cunningham; J Oates; B R Dix; B J Iacopetta; J Young; T Walsh; R Ward; N Hawkins; M Beranek; P Jandik; R Benamouzig; E Jullian; P Laurent-Puig; S Olschwang; O Muller; I Hoffmann; H M Rabes; C Zietz; C Troungos; C Valavanis; S T Yuen; J W Ho; C T Croke; D P O'Donoghue; W Giaretti; A Rapallo; A Russo; V Bazan; M Tanaka; K Omura; T Azuma; T Ohkusa; T Fujimori; Y Ono; M Pauly; C Faber; R Glaesener; A F de Goeij; J W Arends; S N Andersen; T Lövig; J Breivik; G Gaudernack; O P Clausen; P D De Angelis; G I Meling; T O Rognum; R Smith; H S Goh; A Font; R Rosell; X F Sun; H Zhang; J Benhattar; L Losi; J Q Lee; S T Wang; P A Clarke; S Bell; P Quirke; V J Bubb; J Piris; N R Cruickshank; D Morton; J C Fox; F Al-Mulla; N Lees; C N Hall; D Snary; K Wilkinson; D Dillon; J Costa; V E Pricolo; S D Finkelstein; J S Thebo; A J Senagore; S A Halter; S Wadler; S Malik; K Krtolica; N Urosevic
Journal:  Br J Cancer       Date:  2001-09-01       Impact factor: 7.640

10.  KRASG12C Inhibition with Sotorasib in Advanced Solid Tumors.

Authors:  David S Hong; Marwan G Fakih; John H Strickler; Jayesh Desai; Gregory A Durm; Geoffrey I Shapiro; Gerald S Falchook; Timothy J Price; Adrian Sacher; Crystal S Denlinger; Yung-Jue Bang; Grace K Dy; John C Krauss; Yasutoshi Kuboki; James C Kuo; Andrew L Coveler; Keunchil Park; Tae Won Kim; Fabrice Barlesi; Pamela N Munster; Suresh S Ramalingam; Timothy F Burns; Funda Meric-Bernstam; Haby Henary; Jude Ngang; Gataree Ngarmchamnanrith; June Kim; Brett E Houk; Jude Canon; J Russell Lipford; Gregory Friberg; Piro Lito; Ramaswamy Govindan; Bob T Li
Journal:  N Engl J Med       Date:  2020-09-20       Impact factor: 176.079

View more
  2 in total

1.  Gene Alterations, Mediators, and Artificial Intelligence in Colorectal Liver Metastases.

Authors:  Doris Wagner; Georgios Antonios Margonis
Journal:  Cells       Date:  2022-07-15       Impact factor: 7.666

Review 2.  Precision surgery for colorectal liver metastases: Current knowledge and future perspectives.

Authors:  Georgios Antonios Margonis; Jean-Nicolas Vauthey
Journal:  Ann Gastroenterol Surg       Date:  2022-06-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.